Depression and anxiety related subtypes in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2011-01-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/jnnp.2010.213652PMID 21217155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The identification of Parkinson's disease subtypes using cluster analysis: A systematic review

  2010influential reference
• Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study

  2010cited by this paper
• Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.

  2009cited by this paper
• The association between motor subtypes and psychopathology in Parkinson's disease.

  2009cited by this paper
• A clinico-pathological study of subtypes in Parkinson's disease.

  2009cited by this paper
• Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

  2009cited by this paper
• A controlled trial of antidepressants in patients with Parkinson disease and depression

  2009cited by this paper
• Addenbrooke’s Cognitive Examination validation in Parkinson’s disease

  2009cited by this paper
• Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease

  2009cited by this paper
• Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

  2008cited by this paper
• Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

  2008cited by this paper
• Imaging Non-Dopaminergic Function in Parkinson’s Disease

  2007cited by this paper
• Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group

  2006cited by this paper
• Heterogeneity of Parkinson's disease.

  2006cited by this paper
• The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening

  2006cited by this paper
• Antidepressant studies in Parkinson's disease: A review and meta‐analysis

  2005influential reference
• Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

  2005cited by this paper
• Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

  2005cited by this paper
• Anxiety disorders in Parkinson's disease.

  2005cited by this paper
• Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients.

  2005cited by this paper
• Psychiatric comorbidity in a population of Parkinson's disease patients

  2004cited by this paper
• Mortality in Parkinson's disease and its association with dementia and depression

  2004cited by this paper
• Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition.

  2004cited by this paper
• [Heterogeneity of Parkinson's disease].

  2003cited by this paper
• Psychopathological Symptoms of Depression in Parkinson’s Disease Compared to Major Depression

  2003cited by this paper
• Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease

  2002cited by this paper
• Parkinson's disease and anxiety

  2001influential reference
• [The Unified Parkinson's Disease Rating Scale].

  2000cited by this paper
• What contributes to quality of life in patients with Parkinson's disease?

  2000cited by this paper
• Parkinsonism

  1998cited by this paper
• Living with a person who has parkinson's disease: The Spouse's perspective by stage of disease

  1998cited by this paper
• The occurrence of depression in Parkinson's disease. A community-based study.

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease.

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Depression and disability in Parkinson's disease: a follow-up of 132 cases

  1988cited by this paper
• The Hospital Anxiety and Depression Scale.

  1987cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule: I. Development and reliability

  1976cited by this paper
• A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule: II. A factor analysis

  1976cited by this paper
• Book Review: Third Symposium on Parkinson's Disease

  1970cited by this paper
• Projection technique for evaluating surgery in Parkinson’s disease

  1969cited by this paper
• Parkinsonism

  1967cited by this paper

• Characterization of motor and non-motor features associated with bilateral nigral degeneration due to A53T alpha-synuclein in female rats

  2026cites this paper
• Validation of the English version of the Parkinson Anxiety Scale in two Canadian Parkinson’s disease samples

  2025cites this paper
• Management of Anxiety in Parkinson's Disease

  2025influential citation
• Leveraging animal models to understand non-motor symptoms of Parkinson's disease.

  2025cites this paper
• Depression and Anxiety in Parkinson’s Disease: Prevalence and Associated Risk Factors

  2025cites this paper
• CBT for psychosis in Parkinson's disease: A framework for how and why.

  2025cites this paper
• Motor, affective, cognitive, and perceptual symptom changes over time in individuals with Parkinson’s disease who develop freezing of gait

  2025cites this paper
• Emotional Contribution to Parkinson's Disease Diagnosis Using Machine Learning for EEG Dataset Generation

  2025cites this paper
• The relationship between physical function and psychological symptoms in Parkinson’s: Perceptions of People with Parkinson’s and Carers

  2025cites this paper
• Examining the Relationship Between Physical Function and Anxiety/Depression in Parkinson's

  2025cites this paper
• Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis

  2024cites this paper
• Psycho-physical interactions in Parkinson’s Disease: Protocol for a prospective observational cohort study

  2024cites this paper
• The relationship between physical function and psychological symptoms in Parkinson's disease: A systematic review and meta‐regression analysis

  2024cites this paper
• A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms.

  2024cites this paper
• DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson’s Disease: Susceptibility and Protective Effects

  2024cites this paper
• Risk of Parkinson’s disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care

  2024cites this paper
• Predictors of stress resilience in Parkinson’s disease and associations with symptom progression

  2024cites this paper
• Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease

  2024cites this paper
• GABAergic imbalance in Parkinson’s disease–related depression determined with MEGA-PRESS

  2024cites this paper
• Beyond shallow feelings of complex affect: Non-motor correlates of subjective emotional experience in Parkinson’s disease

  2023cites this paper
• A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation.

  2023cites this paper
• Neurobiology of Depression in Parkinson's disease: Insights into Epidemiology, Molecular Mechanisms and Treatment Strategies.

  2023cites this paper
• Parkinson’s Disease Non-Motor Subtypes Classification in a Group of Slovenian Patients: Actuarial vs. Data-Driven Approach

  2023cites this paper
• Development of anxiety in early Parkinson's disease: A clinical and biomarker study

  2023cites this paper
• Effects of Popping For Parkinson’s dance class on the mood of people with Parkinson’s disease

  2023cites this paper
• The pathobiological basis of depression in Parkinson disease: challenges and outlooks

  2022cites this paper
• Neuropsychiatrische symptomen bij de ziekte van Parkinson: een gevalsbeschrijving

  2022cites this paper
• Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson’s disease

  2022cites this paper
• Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases

  2022cites this paper
• Prevalence and Correlates of Psychiatric Comorbidity and Multimorbidity in Parkinson’s Disease and Atypical Parkinsonian Syndromes

  2022cites this paper
• Data-driven subtype classification of patients with early-stage multiple system atrophy.

  2022cites this paper
• Phenomenology of Atypical Anxiety Disorders in Parkinson's Disease: A Systematic Review.

  2022cites this paper
• Predictors of anxiety in Parkinson’s disease: results from a 3-year longitudinal cohort study

  2022influential citation
• Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway.

  2021cites this paper
• Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson’s

  2021cites this paper
• Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease

  2021cites this paper
• Demoralization and Quality of Life of Patients with Parkinson Disease

  2021cites this paper
• Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation

  2021cites this paper
• Anxiety and cognitive load affect upper limb motor control in Parkinson's disease during medication phases

  2021cites this paper
• Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study.

  2021cites this paper
• Nonmotor symptoms and quality of life in Parkinson’s disease with different motor subtypes

  2021cites this paper
• Psychiatric Comorbidities Affect the Hospitalization Course of Parkinson’s Disease Patients: A Cross-Sectional Inpatient Study

  2021cites this paper
• Non-motor Symptoms in Parkinson’s Disease

  2020cites this paper
• Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s Disease

  2020cites this paper
• Depression and Anxiety in Parkinson Disease.

  2020cites this paper
• Treatment of Nonmotor Symptoms Associated with Parkinson Disease.

  2020cites this paper
• Clinically relevant connectivity features define three subtypes of Parkinson's disease patients

  2020cites this paper
• What contributes to quality of life in Parkinson’s disease: a re-evaluation

  2020cites this paper
• Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)

  2020cites this paper
• Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?

  2020cites this paper
• Pharmacotherapeutic Strategies to Treat or Prevent OFF Episodes in Adults with Parkinson's disease

  2020cites this paper
• Neuroprotective Effects of Coffee Bioactive Compounds: A Review

  2020cites this paper
• Linking and comparing non-motor symptoms in aging and Parkinson's disease

  2020cites this paper
• Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease

  2020influential citation
• Impact of depression on gait variability in Parkinson's disease.

  2020cites this paper
• The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease

  2020cites this paper
• ‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine

  2020cites this paper
• Therapy of Parkinson’s Disease Subtypes

  2020cites this paper
• Characterisation of metabotropic glutamate receptor 4 as a therapeutic target in Parkinson's disease

  2019cites this paper
• Parkinson's Disease and Parkinsonism.

  2019cites this paper
• The relationship of anxious and depressive symptoms in Parkinson's disease with voxel-based neuroanatomical and functional connectivity measures.

  2019cites this paper
• Neuropsychiatric aspects of Parkinson’s disease

  2019cites this paper
• Brief Psychiatric Screening Questionnaire in Parkinson's Disease

  2019cites this paper
• THE EFFECTS OF TOXOPLASMA GONDII INFECTIONS ON ANXIETY, DEPRESSION AND LEARNING IN OFFSPRINGS OF INFECTED PARENTS

  2019influential citation
• Sleep disturbance subtypes in Parkinson’s disease based on the cross-culturally validated Korean version of the Parkinson’s Disease Sleep Scale-2

  2019cites this paper
• Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease.

  2019cites this paper
• Subtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2

  2019cites this paper
• Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

  2019cites this paper
• Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson’s Disease

  2019cites this paper
• The interactions between non-motor symptoms of Parkinson’s disease

  2018cites this paper
• Personality factors and cognitive functioning in elderly with Parkinson's disease

  2018cites this paper
• 8 Non-Motor Symptoms in Parkinson’s Disease

  2018cites this paper
• Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial

  2018cites this paper
• Relationships between gait and emotion in Parkinson's disease: A narrative review.

  2018cites this paper
• Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

  2018cites this paper
• Diagnostic Overshadowing of Anxiety in Parkinson Disease: Psychosocial Factors and a Cognitive-Behavioral Model

  2018cites this paper
• Re-examining the Parkinsonian Personality hypothesis: A systematic review

  2018cites this paper
• Stress and functional neurological disorders: mechanistic insights

  2018cites this paper
• TITLE : Stress and Functional Neurological Disorders : Mechanistic Insights

  2018cites this paper
• Clinical Markers of Anxiety Subtypes in Parkinson Disease

  2018cites this paper
• Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease.

  2017cites this paper
• Ageing, masculinity and Parkinson's disease: embodied perspectives.

  2017cites this paper
• Neuropsychiatric symptoms in untreated Parkinson’s disease

  2017cites this paper
• MEETING REPORTER

  2017cites this paper
• Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.

  2017cites this paper
• Motion and emotion: anxiety–axial connections in Parkinson’s disease

  2017cites this paper
• 1 Title : An exploration of worry content and catastrophic thinking in middle and older aged adults with and without Parkinson ’ s disease

  2017cites this paper
• Depression and Anxiety in Parkinson's Disease.

  2017cites this paper
• Implications of Circadian Rhythm in Dopamine and Mood Regulation

  2017cites this paper
• Nonmotor Subtyping in Parkinson's Disease.

  2017cites this paper
• What can the treatment of Parkinson's disease learn from dementia care; applying a bio‐psycho‐social approach to Parkinson's disease

  2017cites this paper
• Non-motor features of Parkinson disease

  2017cites this paper
• Distant delivery of a mindfulness-based intervention for people with Parkinson’s disease: the study protocol of a randomised pilot trial

  2017cites this paper
• Premotor Diagnosis of Parkinson’s Disease

  2017cites this paper
• Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson’s Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study

  2016cites this paper
• The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease—a longitudinal cohort study

  2016cites this paper
• Impact of ethnicity on mood disorders in Parkinson's disease

  2016cites this paper
• Emotional manifestations of PD: Neurobiological basis

  2016cites this paper
• Nonmotor features of Parkinson's disease subtypes

  2016cites this paper
• Rumination and behavioural factors in Parkinson's disease depression

  2016cites this paper